CGP 6.78% 6.3¢ consegna group limited

the master says buy, page-6

  1. 294 Posts.
    lightbulb Created with Sketch. 74
    big pharma big money

    "The active ingredient in Gleevec has been available for years, but Novartis filed for a patent on an updated version available in pill form. India's highest court turned down the application on the grounds that the delivery format did not constitute a legitimate innovation."

    http://www.huffingtonpost.com/2013/06/28/obama-generic-drugs_n_3513011.html
 
watchlist Created with Sketch. Add CGP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.